BackgroundPresently, approaches for the early treatment of pathological anxiety in patients with chronic non-communicable diseases are lacking, thus delaying the initiation of symptom management at the early onset of the illness. Proactive psychological and psychiatric support, to alleviate subclinical symptoms of anxiety and to improve the quality of life in patients with chronic non-communicable diseases, is a promising candidate for the role of such therapy.AimsTo investigate and determine the effectiveness of proactive psychological and psychiatric support for alleviating subclinical symptoms of anxiety and improving quality of life, in patients with chronic non-communicable diseases.MethodsThe study design was a monocentric randomised controlled trial with parallel groups. The study, involving 193 inpatients with chronic non-communicable diseases, complied with the ethical and deontological norms in accordance with the principles set out in the Declaration of Helsinki. Instruments used in the study included the Hamilton Anxiety Scale (HAM-A) to assess subclinical symptoms, the Scale of Somatic Symptoms and the Chaban Quality of Life Scale. Block randomisation was used to randomise patients to a 2-month-long study group with a proactive counselling psychiatry model care or a control group with standard regulated treatment for chronic non-communicable diseases. The allocation ratio was 1.15:1 owing to the expectancy of a higher percentage of dropout in the intervention group.ResultsAfter 60 days of treatment (T2), there was a statistically significant difference in all clinical parameters between the study and control groups. The median HAM-A value differed between the groups by 4.87 points, with statistically significant lower results in the study group. The comparison of the study group’s scale values on day 1 and day 60 demonstrated statistically significant changes in all three indicators.ConclusionsOur results support existing evidence for the effectiveness of proactive psychological and psychiatric support to reduce subclinical anxiety and somatisation symptoms and to improve the quality of life for patients with common chronic non-communicable diseases. However, continued research on the effectiveness of proactive psychological and psychiatric support for patients with chronic non-communicable diseases is needed.
In order to develop a complex model of mother-child interaction (MCI) in the families of women with paranoid schizophrenia (PS) 100 families of patients and 50 families of mentally healthy women were examined (woman, man, child). With the help of identification of the family type and analysis of the factors of prediction and prevention of deformation MCI, the prognosis options for each factor are determined. Significant violations of mental health and family functioning were found in families where the mother suffers from PS. Seven main groups of factors (clusters) that determine the current state of MCI were identified: 1) clinical and psychopathological status of a woman; 2) psychoemotional status of the husband; 3) psychosocial functioning of women and men; 4) psychological state of the child; 5) child-parent relationship; 6) marital relations; 7) family functioning. Factors of prediction and pre- vention of MCI deformation were identified among each group. Quantitative indicators, which make up the content of each cluster, were also calculated, which can be used to determine the prognosis of the MCI in each specific family and situation. The identified regularities made it possible to substantiate and develop a complex system of psy- chocorrection of mental disorders in families where the mother is ill with PS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.